Evolus (EOLS) Stock: Buy, Sell, or Hold?
EOLS - Evolus, Inc. Common Stock
$7.84
-0.07 (-0.88%)
▼
5d:
-13.37%
30d:
-3.45%
90d:
+20.43%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When EOLS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: EOLS is down 13.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: EOLS is down 13.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$9.67
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$6.00
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EOLS is currently trading at $7.84, which is considered slightly high relative to its 30-day fair value range of $7.12 to $9.13. The stock's valuation (Forward PE: 28.4) is in line with its historical norms (29.3). Remarkably, the market is currently pricing in an annual earnings decline of 1.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, EOLS is in a strong uptrend. The price is currently testing key support at $7.75. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: EOLS scores 16/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $15.00 (+91.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, EOLS is in a strong uptrend. The price is currently testing key support at $7.75. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: EOLS scores 16/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $15.00 (+91.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$7.12 -
$9.13
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
42.9%
Protect Your Profits
Holding EOLS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Weak technical setup (16/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 91.3% below Wall St target ($15.00)
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$7.12 -
$9.13
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$7.75
Resistance Level
$9.31
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
28.41
Wall Street Target
$15.00
(+91.3%)
Revenue Growth (YoY)
21.2%
Profit Margin
-10.8%
Valuation Discount vs History
-1.0% cheaper
PE vs Historical
28.4 vs 29.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.0%
(market-implied from PE analysis)
1-Year Target
$7.76
(-1%)
2-Year Target
$7.68
(-2%)
3-Year Target
$7.61
(-3%)
3-Yr Target (if PE normalizes)
(PE: 28→29)
$7.85
(+0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 28.4 to 29.3
Stabilization Target:
$8.09
(+3.1%)
PE Expansion Potential:
+3.1%
Share & Embed Analysis
Last updated: September 12, 2026 10:17 PM ET
Data refreshes hourly during market hours. Next update: 11:17 PM
Data refreshes hourly during market hours. Next update: 11:17 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EOLS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
David Moatazedi
SELL
13669 shares
2026-03-20
Rui Avelar
SELL
3119 shares
2026-03-20
David Moatazedi
SELL
116720 shares
2026-03-17
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$212 | 60 HOLD |
|
LQDA
Liquidia Technologies Inc |
STRONG BUY
10 analysts |
$108 | 70 BUY |
|
INDV
Indivior PLC Ordinary Sh… |
STRONG BUY
7 analysts |
$49 | 69 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$108 | 46 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 47 HOLD |
Advanced EOLS Option Strategies
Professional options setups generated by AI based on today's EOLS price and gamma walls.
